Are Investors Undervaluing Stride (LRN) Right Now?
SyntheticMR Receives Regulatory Approval for SyMRI 15 in Switzerland
Stride, Inc. Wins Tech & Learning 2024 Back to School Award for Excellence in Secondary Education
Those Who Invested in Stride (NYSE:LRN) Five Years Ago Are up 221%
Alumis Presents 28-Week Data From Open Label Extension Period Of Phase 2 STRIDE Trial Of ESK-001; Says '28-week Data Show ESK-001 Was Generally Well Tolerated and Most Patients Treated With the Top Dose of 40 Mg Twice Daily Achieved PASI 75'
Stride Publishes Study Revealing Financial Challenges Faced by Millions of Independent Workers
Beanstalk Benefits Launches New Partnerships, Extends Platform to Include Part-Time and Contract Employees
Express News | Medcerts Launches Certified Cing Assistant (CNA) Elearning Program Benefiting Medical Providers, Patients and Aspiring Healthcare Professionals
Barrington Research Maintains Outperform on Stride, Maintains $90 Price Target
Stride Analyst Ratings
Barrington Maintains Stride(LRN.US) With Buy Rating, Maintains Target Price $90
Barrington analyst Alexander Paris maintains $Stride(LRN.US)$ with a buy rating, and maintains the target price at $90.According to TipRanks data, the analyst has a success rate of 59.6% and a total
Stride Inc.: A Strong Buy on Robust Financials and Market Positioning
The 30 Highest Quant-ranked Consumer Discretionary Stocks as Société Générale Upgrades Sector
ICA Compliance Awards Partners Exclusively With LRN
Stride, Inc. (LRN) Hits Fresh High: Is There Still Room to Run?
Stride, Inc. Named Best EdTech Company by Global EdTech Awards
Is There An Opportunity With Stride, Inc.'s (NYSE:LRN) 50% Undervaluation?
Are Consumer Discretionary Stocks Lagging Stride (LRN) This Year?
Stride Tutoring Moves Families Into the Future With Affordable Online Tutoring
Zacks Industry Outlook Highlights Grand Canyon, Stride and Lincoln Educational